(Q65383585)
Statements
A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered With Venlafaxine in Subjects With Major Depressive Disorder (MDD) and Co-existing Insomnia (English)
0 references
June 2007
0 references
July 2009
0 references
678
0 references
18 year
0 references
64 year
0 references